tiprankstipranks
EyePoint Pharmaceuticals Inc (EYPT)
NASDAQ:EYPT

EyePoint Pharmaceuticals (EYPT) Financial Statements

753 Followers

EyePoint Pharmaceuticals Financial Overview

EyePoint Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.826; its P/E ratio is -6.09; EyePoint Pharmaceuticals is scheduled to report earnings on July 31, 2024, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 15.20M$ 5.27M$ 7.68M$ 10.53M$ 10.01M
Gross Profit$ 15.20M$ 9.11M$ 7.68M$ 10.53M$ 8.61M
EBIT$ -10.21M$ -18.90M$ -20.35M$ -42.67M$ -17.76M
EBITDA$ -10.09M$ -18.77M$ -20.25M-$ -17.05M
Net Income Common Stockholders$ -12.61M$ -22.92M$ -21.16M$ -43.45M$ -18.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 136.03M$ 142.50M$ 122.47M$ 144.53M$ 157.26M
Total Assets$ 160.04M$ 175.62M$ 154.59M$ 178.97M$ 220.49M
Total Debt$ 5.18M$ 5.46M$ 40.39M$ 45.77M$ 46.46M
Net Debt$ -130.85M$ -137.04M$ -82.08M$ -98.76M$ -110.80M
Total Liabilities$ 101.42M$ 118.39M$ 76.20M$ 180.36M$ 84.14M
Stockholders Equity$ 58.62M$ 57.26M$ 78.39M$ 96.37M$ 136.35M
Cash Flow-
Free Cash Flow$ -16.92M$ 56.63M$ -17.32M$ -13.08M$ -14.33M
Operating Cash Flow$ -15.20M$ 57.02M$ -16.84M$ -12.49M$ -13.14M
Investing Cash Flow$ -1.72M$ 13.47M$ 32.09M$ 32.92M$ 6.27M
Financing Cash Flow$ 10.36M$ -36.66M$ -5.12M$ -58.00K$ 92.00K
Currency in USD

EyePoint Pharmaceuticals Earnings and Revenue History

EyePoint Pharmaceuticals Debt to Assets

EyePoint Pharmaceuticals Cash Flow

EyePoint Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis